IQVIA’s 2025 MedTech outlook highlights ten key trends: growing investment in clinical AI despite data and regulatory hurdles; limited policy impact from the new U.S. administration; legal and compliance uncertainty around the FDA’s LDT rule; continued rise of real-world evidence (RWE); and urgent cybersecurity needs amid increasing threats. Other trends include 3D printing growth, evolving market access in China, persistent supply chain risks, early signs of improved reimbursement pathways, and the need to prepare for EU Health Technology Assessments. These dynamics signal a year of cautious innovation and regulatory adaptation.

Join for free to read